1241 Clusters of multi-organ toxicities are associated with improved survival among immune checkpoint inhibitor recipients: a population-level study
Main Authors: | , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |
_version_ | 1797630658652143616 |
---|---|
author | Kun-Hsing Yu Shadmehr Demehri Nga Nguyen Leyre Zubiri Kerry Reynolds Alexander Gusev Shawn Kwatra Yevgeniy R Semenov Nicole R LeBoeuf Jayhyun Seo William Lotter Katie Roster Wenxin Chen Guihong Wan Ahmad Rajesh Hannah Rashdan |
author_facet | Kun-Hsing Yu Shadmehr Demehri Nga Nguyen Leyre Zubiri Kerry Reynolds Alexander Gusev Shawn Kwatra Yevgeniy R Semenov Nicole R LeBoeuf Jayhyun Seo William Lotter Katie Roster Wenxin Chen Guihong Wan Ahmad Rajesh Hannah Rashdan |
author_sort | Kun-Hsing Yu |
collection | DOAJ |
first_indexed | 2024-03-11T11:11:19Z |
format | Article |
id | doaj.art-2db26149663644138c8caab863d52e03 |
institution | Directory Open Access Journal |
issn | 2051-1426 |
language | English |
last_indexed | 2024-03-11T11:11:19Z |
publishDate | 2023-11-01 |
publisher | BMJ Publishing Group |
record_format | Article |
series | Journal for ImmunoTherapy of Cancer |
spelling | doaj.art-2db26149663644138c8caab863d52e032023-11-12T02:25:07ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262023-11-0111Suppl 110.1136/jitc-2023-SITC2023.12411241 Clusters of multi-organ toxicities are associated with improved survival among immune checkpoint inhibitor recipients: a population-level studyKun-Hsing Yu0Shadmehr Demehri1Nga Nguyen2Leyre Zubiri3Kerry Reynolds4Alexander Gusev5Shawn Kwatra6Yevgeniy R Semenov7Nicole R LeBoeuf8Jayhyun Seo9William Lotter10Katie Roster11Wenxin Chen12Guihong Wan13Ahmad Rajesh14Hannah Rashdan152Harvard Medical School, Boston, MA, USADepartment of Dermatology, Massachusetts General Hospital, Boston, Massachusetts, USADepartment of Health Education, Faculty of Social Science, Behavior and Health Education, Hanoi University of Public Health, Hanoi, Vietnam1MGH, Boston, MA, USA1Massachusetts General Hospital, Boston, MA, USADepartment of Medicine, Dana-Farber Cancer Institute, Boston, Massachusetts, USA4Johns Hopkins University, Baltimore, MD, USADepartment of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA2Dana Farber Cancer Institute, Boston, MA, USA1Massachusetts General Hospital, Boston, MA, USA1Dana-Farber Cancer Institute, Boston, MA, USA1Massachusetts General Hospital, Boston, MA, USA1Massachusetts General Hospital, Boston, MA, USA1Massachusetts General Hospital, Boston, MA, USA1Massachusetts General Hospital, Boston, MA, USA1Massachusetts General Hospital, Boston, MA, USA |
spellingShingle | Kun-Hsing Yu Shadmehr Demehri Nga Nguyen Leyre Zubiri Kerry Reynolds Alexander Gusev Shawn Kwatra Yevgeniy R Semenov Nicole R LeBoeuf Jayhyun Seo William Lotter Katie Roster Wenxin Chen Guihong Wan Ahmad Rajesh Hannah Rashdan 1241 Clusters of multi-organ toxicities are associated with improved survival among immune checkpoint inhibitor recipients: a population-level study Journal for ImmunoTherapy of Cancer |
title | 1241 Clusters of multi-organ toxicities are associated with improved survival among immune checkpoint inhibitor recipients: a population-level study |
title_full | 1241 Clusters of multi-organ toxicities are associated with improved survival among immune checkpoint inhibitor recipients: a population-level study |
title_fullStr | 1241 Clusters of multi-organ toxicities are associated with improved survival among immune checkpoint inhibitor recipients: a population-level study |
title_full_unstemmed | 1241 Clusters of multi-organ toxicities are associated with improved survival among immune checkpoint inhibitor recipients: a population-level study |
title_short | 1241 Clusters of multi-organ toxicities are associated with improved survival among immune checkpoint inhibitor recipients: a population-level study |
title_sort | 1241 clusters of multi organ toxicities are associated with improved survival among immune checkpoint inhibitor recipients a population level study |
work_keys_str_mv | AT kunhsingyu 1241clustersofmultiorgantoxicitiesareassociatedwithimprovedsurvivalamongimmunecheckpointinhibitorrecipientsapopulationlevelstudy AT shadmehrdemehri 1241clustersofmultiorgantoxicitiesareassociatedwithimprovedsurvivalamongimmunecheckpointinhibitorrecipientsapopulationlevelstudy AT nganguyen 1241clustersofmultiorgantoxicitiesareassociatedwithimprovedsurvivalamongimmunecheckpointinhibitorrecipientsapopulationlevelstudy AT leyrezubiri 1241clustersofmultiorgantoxicitiesareassociatedwithimprovedsurvivalamongimmunecheckpointinhibitorrecipientsapopulationlevelstudy AT kerryreynolds 1241clustersofmultiorgantoxicitiesareassociatedwithimprovedsurvivalamongimmunecheckpointinhibitorrecipientsapopulationlevelstudy AT alexandergusev 1241clustersofmultiorgantoxicitiesareassociatedwithimprovedsurvivalamongimmunecheckpointinhibitorrecipientsapopulationlevelstudy AT shawnkwatra 1241clustersofmultiorgantoxicitiesareassociatedwithimprovedsurvivalamongimmunecheckpointinhibitorrecipientsapopulationlevelstudy AT yevgeniyrsemenov 1241clustersofmultiorgantoxicitiesareassociatedwithimprovedsurvivalamongimmunecheckpointinhibitorrecipientsapopulationlevelstudy AT nicolerleboeuf 1241clustersofmultiorgantoxicitiesareassociatedwithimprovedsurvivalamongimmunecheckpointinhibitorrecipientsapopulationlevelstudy AT jayhyunseo 1241clustersofmultiorgantoxicitiesareassociatedwithimprovedsurvivalamongimmunecheckpointinhibitorrecipientsapopulationlevelstudy AT williamlotter 1241clustersofmultiorgantoxicitiesareassociatedwithimprovedsurvivalamongimmunecheckpointinhibitorrecipientsapopulationlevelstudy AT katieroster 1241clustersofmultiorgantoxicitiesareassociatedwithimprovedsurvivalamongimmunecheckpointinhibitorrecipientsapopulationlevelstudy AT wenxinchen 1241clustersofmultiorgantoxicitiesareassociatedwithimprovedsurvivalamongimmunecheckpointinhibitorrecipientsapopulationlevelstudy AT guihongwan 1241clustersofmultiorgantoxicitiesareassociatedwithimprovedsurvivalamongimmunecheckpointinhibitorrecipientsapopulationlevelstudy AT ahmadrajesh 1241clustersofmultiorgantoxicitiesareassociatedwithimprovedsurvivalamongimmunecheckpointinhibitorrecipientsapopulationlevelstudy AT hannahrashdan 1241clustersofmultiorgantoxicitiesareassociatedwithimprovedsurvivalamongimmunecheckpointinhibitorrecipientsapopulationlevelstudy |